Strategic Analysis Case Study
CVS Health Corp.
NYS: CVS
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for CVS Health Corp.
|
|
2014 |
2015 |
2016 |
2017 |
2018 |
5-year trend |
|
SG&A Expense |
16.57B |
16.85B |
18.27B |
18.52B |
20.75B |
|
|
Research & Development |
- |
- |
- |
- |
- |
|
|
Other SG&A |
16.57B |
16.85B |
18.27B |
18.52B |
20.75B |
|
|
SGA Growth |
- |
1.69% |
8.41% |
1.36% |
12.02% |
|
|
Other Operating Expense |
- |
- |
- |
- |
- |
|
|
Unusual Expense |
515M |
220M |
936M |
470M |
6.68B |
|
|
EBIT after Unusual Expense |
8.28B |
(220M) |
9.7B |
(470M) |
4.11B |
|
|
Non Operating Income/Expense |
(4M) |
2M |
2M |
(206M) |
(100M) |
|
|
Non-Operating Interest Income |
15M |
21M |
20M |
- |
- |
|
|
Equity in Affiliates (Pretax) |
- |
- |
- |
- |
- |
|
|
Interest Expense |
611M |
861M |
1.08B |
1.06B |
2.6B |
|
|
Interest Expense Growth |
- |
40.92% |
25.44% |
-1.48% |
144.36% |
|
|
Gross Interest Expense |
630M |
873M |
1.09B |
1.06B |
2.6B |
|
|
Interest Capitalized |
19M |
12M |
13M |
- |
- |
|
|
Pretax Income |
7.68B |
8.62B |
8.64B |
8.27B |
1.41B |
|
|
Pretax Income Growth |
- |
12.22% |
0.24% |
-4.27% |
-82.99% |
|
|
Pretax Margin |
- |
- |
- |
- |
0.72% |
NA |
|
Income Tax |
3.03B |
3.39B |
3.32B |
1.64B |
2B |
|
|
Income Tax - Current Domestic |
3.08B |
3.62B |
3.31B |
3.06B |
1.98B |
|
|
Income Tax - Current Foreign |
- |
- |
- |
- |
- |
|
|
Income Tax - Deferred Domestic |
(43M) |
(234M) |
3M |
(1.42B) |
23M |
|
|
Income Tax - Deferred Foreign |
- |
- |
- |
- |
- |
|
|
Income Tax Credits |
- |
- |
- |
- |
- |
|
|
Equity in Affiliates |
- |
- |
- |
- |
- |
|
|
Other After Tax Income (Expense) |
(18M) |
(26M) |
(27M) |
(24M) |
(3M) |
|
|
Consolidated Net Income |
4.63B |
5.2B |
5.29B |
6.61B |
(599M) |
|
|
Minority Interest Expense |
- |
2M |
2M |
1M |
(2M) |
|
|
Net Income |
4.63B |
5.2B |
5.29B |
6.61B |
(597M) |
|
|
Net Income Growth |
- |
12.43% |
1.71% |
24.85% |
-109.04% |
|
|
Net Margin Growth |
- |
- |
- |
- |
-0.31% |
NA |
|
Extraordinaries & Discontinued Operations |
(1M) |
9M |
(1M) |
(8M) |
- |
|
|
Extra Items & Gain/Loss Sale Of Assets |
(1M) |
- |
- |
- |
- |
|
|
Cumulative Effect - Accounting Chg |
- |
- |
- |
- |
- |
|
|
Discontinued Operations |
- |
9M |
(1M) |
(8M) |
- |
|
|
Net Income After Extraordinaries |
4.63B |
5.21B |
5.29B |
6.6B |
(597M) |
|
|
Preferred Dividends |
- |
- |
- |
- |
- |
|
|
Net Income Available to Common |
4.63B |
5.21B |
5.29B |
6.6B |
(597M) |
|
|
EPS (Basic) |
3.99 |
4.66 |
4.93 |
6.47 |
(0.57) |
|
|
EPS (Basic) Growth |
- |
16.93% |
5.79% |
31.24% |
-108.81% |
|
|
Basic Shares Outstanding |
1.16B |
1.12B |
1.07B |
1.02B |
1.04B |
|
|
EPS (Diluted) |
3.96 |
4.63 |
4.90 |
6.44 |
(0.57) |
|
|
EPS (Diluted) Growth |
- |
16.98% |
5.83% |
31.43% |
-108.85% |
|
|
Diluted Shares Outstanding |
1.17B |
1.13B |
1.08B |
1.02B |
1.04B |
|
|
EBITDA |
10.71B |
11.79B |
13.13B |
12.53B |
13.49B |
|
|
EBITDA Growth |
- |
10.03% |
11.38% |
-4.58% |
7.70% |
|
|
EBITDA Margin |
- |
- |
- |
- |
6.93% |
NA |
Copyright 2020 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals
CVS Health Corp.
NYS: CVS
Market Index
Income Statement
Balance Sheet
Cash Flow Statement
Annual Financials for CVS Health Corp.
Fiscal year is January
-
December.
All values USD millions.
2014
2015
2016
2017
2018
5
-
year trend
Sales/Revenue
139.37B
153.29B
177.53B
184.79B
194.58B
Sales Growth
-
9.99%
15.81%
4.09%
5.30%
Cost of Goods Sold (COGS) incl.
D&A
114B
126.76B
148.62B
156.26B
163.04B
COGS excluding D&A
112.08B
124.65B
146.13B
153.74B
160.34B
Depreciation & Amortization
Expense
1.92B
2.11B
2.5B
2.52B
2.7B
Depreciation
1.4B
1.5B
1.7B
1.7B
1.7B
Amortization of
Intangibles
518M
611M
795M
817M
1B
COGS Growth
-
11.19%
17.25%
5.14%
4.34%
Gross Income
25.37B
26.53B
28.9B
28.53B
31.54B
Gross Income Growth
-
4.58%
8.95%
-
1.30%
10.55%
Gross Profit Margin
-
-
-
-
16.21%
NA
2014
2015
2016
2017
2018
5
-
year trend
SG&
A Expense
16.57B
16.85B
18.27B
18.52B
20.75B
Research & Development
-
-
-
-
-
Other SG&A
16.57B
16.85B
18.27B
18.52B
20.75B
SGA Growth
-
1.69%
8.41%
1.36%
12.02%
Other Operating Expense
-
-
-
-
-
CVS Health Corp.
NYS: CVS
Market Index
Income StatementBalance SheetCash Flow Statement
Annual Financials for CVS Health Corp.
Fiscal year is January-December.
All values USD millions.
2014 2015 2016 2017 2018 5-year trend
Sales/Revenue 139.37B 153.29B 177.53B 184.79B 194.58B
Sales Growth - 9.99% 15.81% 4.09% 5.30%
Cost of Goods Sold (COGS) incl.
D&A
114B 126.76B 148.62B 156.26B 163.04B
COGS excluding D&A 112.08B 124.65B 146.13B 153.74B 160.34B
Depreciation & Amortization
Expense
1.92B 2.11B 2.5B 2.52B 2.7B
Depreciation 1.4B 1.5B 1.7B 1.7B 1.7B
Amortization of
Intangibles
518M 611M 795M 817M 1B
COGS Growth - 11.19% 17.25% 5.14% 4.34%
Gross Income 25.37B 26.53B 28.9B 28.53B 31.54B
Gross Income Growth - 4.58% 8.95% -1.30% 10.55%
Gross Profit Margin - - - - 16.21% NA
2014 2015 2016 2017 2018 5-year trend
SG&A Expense 16.57B 16.85B 18.27B 18.52B 20.75B
Research & Development - - - - -
Other SG&A 16.57B 16.85B 18.27B 18.52B 20.75B
SGA Growth - 1.69% 8.41% 1.36% 12.02%
Other Operating Expense - - - - -